Buyer profile
HUS Group, the joint authority for Helsinki and Uusimaa
FI- Awards
- 24
- Total awarded value
- €116,124,856
- Countries
- countries.FI
- Latest award
- May 15, 2026
- Expiring within 12 months
- 6
Award history
| Date | Vendor | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 05/15/2026 | BeOne Medicines, GmbH, Dutch Branch | Finland – Pharmaceutical products – Tislelitsumabin (Tevimbra) hankinta | — | €1.0M | FI | 12/31/2026 | View on TED ↗ |
| 03/11/2026 | MSD Finland Oy | Finland – Pharmaceutical products – Sotaterseptivalmisteen (Winrevair) hankinta | — | €500.0K | FI | 12/31/2026 | View on TED ↗ |
| 02/09/2026 | Recordati AB | Finland – Pharmaceutical products – Osilodrostaatin (Isturisa 1 mg, 5 mg ja 10 mg) hankinta | — | €600.0K | FI | 12/31/2026 | View on TED ↗ |
| 01/29/2026 | Ascendis Pharma A/S | Finland – Pharmaceutical products – Palopegteriparatidivalmisteen (Yorvipath) hankinta | — | €760.0K | FI | 12/31/2026 | View on TED ↗ |
| 01/28/2026 | Novartis Finland Oy | Finland – Pharmaceutical products – Tisagenlekleuseelivalmiste (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikuispotilaille | — | €2.0M | FI | 12/31/2027 | View on TED ↗ |
| 01/28/2026 | Biogen Finland Oy | Finland – Pharmaceutical products – Nusinerseenin (Spinraza) hankinta | — | €1.0M | FI | 12/31/2026 | View on TED ↗ |
| 11/18/2025 | Oy Bristol Myers Squibb (Finland) Ab | Finland – Pharmaceutical products – CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2026 – 31.12.2027 | — | €20.0M | FI | 12/31/2027 | View on TED ↗ |
| 08/27/2025 | Sanofi Oy | Finland – Pharmaceutical products – Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, liuos, esitäytetty ruisku) hankinta RSV-kaudelle 2025-2026 | — | €10.5M | FI | 03/31/2026 | View on TED ↗ |
| 04/14/2025 | Novartis Finland Oy | Finland – Pharmaceutical products – Tisagenlekleuseeli (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikauispotilaille | — | €4.5M | FI | 12/31/2025 | View on TED ↗ |
| 03/03/2025 | Ascendis Pharma A/S | Finland – Pharmaceutical products – Palopegteriparatidivalmisteen (Yorvipath) hankinta | — | €700.0K | FI | 12/31/2025 | View on TED ↗ |
| 02/10/2025 | Gilead Sciences Finland Oy | Finland – Antineoplastic and immunomodulating agents – CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2025 – 31.12.2025 | — | €33.0M | FI | 12/31/2025 | View on TED ↗ |
| 02/10/2025 | Immunocore Ireland Ltd | Finland – Pharmaceutical products – Tebentafuspivalmisteen (Kimmtrak 100 mikrogrammaa/0,5 mlinfuusiokonsentraatti, liuosta varten) hankinta | — | €3.1M | FI | — | View on TED ↗ |
| 01/30/2025 | Novartis Finland Oy | Finland – Pharmaceutical products – Onasemnogeeniabeparvoveekki-infuusionesteen (Zolgensma® 2x10exp13 vektorigenomia/ml infuusioneste, liuos) hankinta | — | €8.0M | FI | 12/31/2026 | View on TED ↗ |
| 01/14/2025 | Biogen Finland Oy | Finland – Pharmaceutical products – Nusinerseenivalmisteen (Spinraza 12 mg injektioliuos) hankinta | — | €1.0M | FI | — | View on TED ↗ |
| 01/14/2025 | Janssen-Cilag Oy | Finland – Pharmaceutical products – Talketamabivalmisteen (Talvey) hankinta | — | €260.0K | FI | 12/31/2025 | View on TED ↗ |
| 01/13/2025 | Gilead Sciences Finland Oy | Finland – Pharmaceutical products – Breksukabtageeni autoleuseeli -valmisteen (Tecartus® 0,4 – 2 × 108 solua infuusioneste, dispersio) hankinta | — | €3.0M | FI | 12/31/2025 | View on TED ↗ |
| 10/30/2024 | Finland – Antineoplastic and immunomodulating agents – Keskeytysilmoitus: CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2025 – 31.12.2025 | — | — | FI | 12/31/2025 | View on TED ↗ | |
| 08/27/2024 | Sanofi Oy | Finland – Pharmaceutical products – Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, liuos, esitäytetty ruisku) hankinta RSV-kaudelle 2024-2025 | — | €14.0M | FI | — | View on TED ↗ |
| 05/28/2024 | Bio-Rad Finland Oy | Finland – Chemical reagents – Quality Assurance samples and Calibrators for HUS Laboratory of Endocrinology and Metabolism | — | €306.9K | FI | — | View on TED ↗ |
| 05/02/2024 | Oy Bristol Myers Squibb (Finland) Ab | Finland – Medical equipments, pharmaceuticals and personal care products – Nivolumabin ja relatlimabin yhdistelmävalmisteen hankinta | — | €1.4M | FI | 12/31/2025 | View on TED ↗ |
| 02/29/2024 | Gilead Sciences Finland Oy | Finland – Antivirals for systemic use – Bulevirtidivalmiste (Hepcludex® 2 mg injektiokuiva-aine) suorahankinta | — | €1.2M | FI | 12/31/2024 | View on TED ↗ |
| 02/28/2024 | Gilead Sciences Finland Oy | Finland – Pharmaceutical products – Remdesiviirin (Veklury 100 mg kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos) suorahankinta | — | €1.0M | FI | 12/31/2024 | View on TED ↗ |
| 02/28/2024 | Pfizer Oy | Finland – Pharmaceutical products – Nirmatrelviirin ja ritonaviirin yhdistelmävalmisteen (PAXLOVID tabletti, kalvopäällysteinen 150 mg + 100 mg) suorahankinta | — | €8.0M | FI | 12/31/2024 | View on TED ↗ |
| 10/31/2023 | Finland – Medical equipments – K2513500005 ERG-device with FST | — | €298.0K | FI | — | View on TED ↗ |